Back
Portage Biotech 10K Form
Sell
16
PRTG
Portage Biotech
Last Price:
3.17
Seasonality Move:
5196.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PRTG News And Ratings
See the #1 stock for the next 7 days that we like better than PRTG
PRTG Financial Statistics
Sales & Book Value
| Annual Sales: | $6.26K |
|---|---|
| Cash Flow: | $-1.56M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.25 |
| Price / Book: | 3.06 |
Profitability
| EPS (TTM): | -94.66000 |
|---|---|
| Net Income (TTM): | $-67.28M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Portage Biotech Earnings Forecast
Key Portage Biotech Financial Ratios
- The Selling, General & Administrative Expenses for PRTG have been equal to 10,079.87% of Gross Profit Margin.
- The Interest Expense is -0.04% of Operating Income.
- Per Share Earnings over the last 27 years have been positive in 15 years.
Portage Biotech Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PRTG |
| Website: | portagebiotech.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PRTG Technical Analysis vs Fundamental Analysis
Sell
16
Portage Biotech (PRTG)
is a Sell
Is Portage Biotech a Buy or a Sell?
-
Portage Biotech stock is rated a Sell
The current Portage Biotech [PRTG] share price is $3.00. The Score for PRTG is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.